Latest News
Search News
Professor Victoria Sanz-Moreno recognised for major contributions in the fight against melanoma
17th October 2022
Congratulations to Professor Victoria Sanz-Moreno from Barts Cancer Institute at Queen Mary University of London who has received the Estela Medrano Memorial Award from the Society of Melanoma Research, which honours women who have made major contributions in the fight against melanoma.
Read more
The REMODEL project: Remodelling tumour microenvironments to improve immunotherapy
12th October 2022
Professor Fran Balkwill from Barts Cancer Institute at Queen Mary University of London has received a UK Research and Innovation (UKRI) Frontier Research grant of over £2 million to investigate the most effective ways to remodel cancers to enhance the effects of immunotherapy.
Read more
BCI PhD Day – Celebrating the work of our postgraduate research students
7th October 2022
After taking place online for the last two years running, we were pleased to be able to hold this year’s annual BCI PhD Day in person on 15th September. Organised by the BCI PhD Forum, PhD Day celebrates the work of our postgraduate research students and provides the opportunity for them to showcase their research to fellow students and academics.
Read more
Celebrating a New Milestone at the PCRF Tissue Bank
29th September 2022
Recently, the PCRF Tissue Bank registered its 1,000th tissue donor, reaching a new milestone. We spoke with Amina Saad, who is responsible for over 660 donor registrations, including the Tissue Bank’s 1,000th registration, about her role as a Tissue Collection Officer within the Tissue Bank team.
Read more
Study identifies how cancer-causing gene regulates genetic variation in prostate cancer
27th September 2022
Researchers from Barts Cancer Institute at Queen Mary University of London, the Italian Institute for Genomic Medicine, and the University of Milan have identified a novel role for a cancer-causing gene in controlling an important genetic process that underpins genetic variation in prostate cancer.
Read more
Understanding the role of cancer’s circular genome in tumour evolution
23rd September 2022
New research, co-led by Dr Benjamin Werner from Barts Cancer Institute at Queen Mary University of London, indicates that the circular DNA structures present in around a third of cancers lead to extensive genetic diversity within tumours, giving them the ability to adapt rapidly to environmental stress and resist targeted cancer treatment.
Read more